Key Points Vivos Therapeutics agreed to acquire an 11% fully diluted stake in SOD Sciences and 50% co-ownership of its proprietary early-warning test. Vivos will…
October 15, 2026
July 29, 2026
Pulse Biosciences Hits Its Stride: NANOPULSE‑AF AFib Pivotal Trial Passes Enrollment Midpoint
The NANOPULSE‑AF study is evaluating the CellFX nano‑second pulsed field ablation (nsPFA) Cardiac Catheter System in people with drug‑resistant, symptomatic paroxysmal atrial fibrillation. The trial…
Soluna Holdings’ (NASDAQ: SLNH) is enjoying a strong bounce today, with shares up roughly 23% and pushing further into the low‑$1 range. This move extends the…